Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Which Approach to SupPORT When the Nodes Don't Get the Memo: Surprise pN2 Disease After Neoadjuvant Chemoimmunotherapy.

International journal of radiation oncology, biology, physics·2026

Same author

Consensus radiation therapy organ at risk constraints for NCTN trials in hematologic malignancies.

Journal of the National Cancer Institute·2026

Same author

Posttraumatic Stress Disorder and Macular, Choroidal, and Peripapillary Perfusion Using Optical Coherence Tomography and Angiography.

Ophthalmic surgery, lasers & imaging retina·2026

Same author

Management of traumatic corneal wounds that do not seal after primary closure: a systematic review.

Eye (London, England)·2026

Same author

In Reply to Jordan.

International journal of radiation oncology, biology, physics·2026

Same author

Understanding the pathogenesis of uveitis in Ebola virus disease survivors: an observational cohort and cross-sectional study protocol for clinical, molecular virologic and immunologic characterisation.

BMJ open·2025

Search research articles

Related Experiment Video

Updated: Dec 19, 2025

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Malpractice Litigation in Vitreoretinal Surgery and Medical Retina.

Stephanie B Engelhard, Grant A Justin, Ingrid E Zimmer-Galler

Ophthalmic Surgery, Lasers & Imaging Retina

|June 9, 2020

Summary

Vitreoretinal surgery and medical retina malpractice litigation frequently involve complex cases like retinal detachment, with jury awards significantly higher than settlements. Most cases favor defendants, but plaintiff verdicts can reach millions.

More Related Videos

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice

Published on: October 5, 2018

Related Experiment Videos

Last Updated: Dec 19, 2025

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice

Published on: October 5, 2018

Area of Science:

Ophthalmology
Medical Law
Retina Surgery

Background:

Vitreoretinal surgery and medical retina treatments carry inherent risks due to complexity and potential for vision loss.
Malpractice litigation in ophthalmology, particularly vitreoretinal cases, warrants detailed analysis of causes and outcomes.

Purpose of the Study:

To analyze the causes and outcomes of malpractice litigation specifically related to vitreoretinal surgery and medical retina cases.
To identify common scenarios leading to litigation and evaluate resolution trends, including jury awards and settlements.

Main Methods:

A comprehensive review of the WestLaw database was conducted for all U.S. vitreoretinal malpractice litigation from 1930 to 2014.
142 retina-specific cases were identified and analyzed for litigation causes, resolution methods, and financial awards.

Main Results:

The majority of cases (64.1%) were resolved in favor of defendants.
Retinal detachment (46.5%) and retinopathy of prematurity (9.2%) were the most frequent conditions leading to litigation.
Plaintiff verdicts from jury trials averaged over $5.2 million, significantly higher than settlement amounts.

Conclusions:

Treating vitreoretinal conditions is high-risk, contributing to frequent malpractice claims.
The potential for substantial financial awards in plaintiff verdicts underscores the significant risks associated with vitreoretinal malpractice litigation.